Sustainable Healthcenter Implementation PrEP Pilot Study

• Status: Unknown status
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified health centers that provide sexual health and primary care services to communities with high HIV incidence/prevalence.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: CDC Foundation
• Collaborator: Gilead Sciences
• Treatments: Tenofovir

Criteria

Inclusion Criteria:

• adult

• documented without HIV infection (acute or established)

• report sexual behaviors that indicate substantial risk of HIV acquisition

• report injection-related behaviors that indicate substantial risk of HIV acquisition

Exclusion Criteria:

• <18 years of age

• documented HIV infection (acute or established)